Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

371.73 -2.25 (-0.60%)
Delayed Quote Updated: 10:28 AM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Which stocks are moving after the closing bell on Monday? ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
3 Reasons CRL is Risky and 1 Stock to Buy Instead
Over the past six months, Charles River Laboratories has been a great trade, beating the S&P 500 by 7.5%. Its stock price has climbed to $168.91, representin... 
Via StockStory
Topics Stocks
Which S&P500 stocks have an unusual volume on Wednesday? ↗
Via Chartmill
Charles River Laboratories (NYSE:CRL) Reports Mixed Q4 2025 Results, Guides for 2026 Growth ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Pack
Via StockStory
News headline image
Charles River Laboratories to Present at TD Cowen and Barclays Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Provides Update on Planned Divestitures
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Integra LifeSciences, Enovis, BrightSpring Health Services, IQVIA, and Charles River Laboratories Shares Plummet, What You Need To Know
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court... 
Via StockStory
Topics Government World Trade
News headline image
CRL Q4 Deep Dive: Flat Sales and Margin Pressures as Biotech Demand Recovers
Lab services company Charles River Laboratories (NYSE:CRL) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales were flat year on year at $994.2 million. Its non-GAAP profit of... 
Via StockStory
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
Charles River (CRL) Earnings Call Transcript ↗
Charles River (CRL) Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Charles River Laboratories (NYSE:CRL) Beats Q4 CY2025 Sales Expectations
Lab services company Charles River Laboratories (NYSE:CRL) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales were flat year on year at $994.2 million. Its non-GAAP profit of... 
Via StockStory
News headline image
Charles River Laboratories Announces Executive Appointments
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories (CRL) Q4 Earnings: What To Expect
Lab services company Charles River Laboratories (NYSE:CRL) will be reporting results this Wednesday before the bell. Here’s what to expect. 
Via StockStory
Topics World Trade
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗
Via Chartmill
News headline image
Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire
Unusual volume S&P500 stocks in Wednesday's session ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Gapping S&P500 stocks in Wednesday's session ↗
Via Chartmill
News headline image
1 S&P 500 Stock with Competitive Advantages and 2 We Ignore
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
News headline image
Charles River Laboratories (CRL): Buy, Sell, or Hold Post Q3 Earnings?
Charles River Laboratories has had an impressive run over the past six months as its shares have beaten the S&P 500 by 20.5%. The stock now trades at $189.18, marking a 27% gain. This was partly thanks... 
Via StockStory
Topics Stocks
News headline image
3 Mid-Cap Stocks That Fall Short
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
Via StockStory
News headline image
1 Unpopular Stock That Should Get More Attention and 2 We Question
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
News headline image
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Enters Manufacturing Collaboration with Gazi University
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.